HealthPhoto: Deccan HeraldIndia Caps Trade Margins on 137 Cancer Drugs at 30%
India has capped trade margins on 137 cancer medicines, including patented drugs like pembrolizumab, ribociclib, and abemaciclib, at 30% over the first point of sale cost. This move aims to balance affordability with quality care. The Supreme Court highlighted concerns about excessive mark-ups and stressed the need for transparent billing and sustainable healthcare economics beyond just price caps.
Deccan Herald·



